Diagnostic and related healthcare service provider Dr Lal PathLabs has posted 51.9 percent fall in its Q1 net profit at Rs 28.4 crore versus Rs 59.1 crore in a year ago period.
Its revenue was down 20.6% at Rs 266 crore against Rs 335.2 crore.
Earnings before interest, tax, depreciation and amortisation (EBITDA) was down 49.2% at Rs 48.3 crore against Rs 95.1 crore, while margin was at 18.2% versus 28.4%, YoY.
At 14:44 hrs Dr Lal PathLabs was quoting at Rs 1,939.35, up Rs 58.25, or 3.10 percent on the BSE.
The share touched its 52-week high Rs 2,029.85 and 52-week low Rs 1,037.60 on 21 July, 2020 and 16 July, 2019, respectively.